CDx Diagnostics
CDx Diagnostics is a leader in diagnostic innovation, developing next-generation AI-powered technology to help physicians detect cancer cells early. Their proprietary platform synthesizes computer imaging, artificial intelligence, molecular biology, and three-dimensional cytopathology to detect precancerous changes more reliably and earlier than previous methods. The company's WATS3D technology is included as an adjunct to routine biopsies for screening and surveillance of Barrett's esophagus in the guidelines of the American Society for Gastrointestinal Endoscopy (ASGE). CDx Diagnostics is expanding its platform to other areas like bile duct, stomach, and colon cancers.
CDx Diagnostics
CDx Diagnostics is a leader in diagnostic innovation, developing next-generation AI-powered technology to help physicians detect cancer cells early. Their proprietary platform synthesizes computer imaging, artificial intelligence, molecular biology, and three-dimensional cytopathology to detect precancerous changes more reliably and earlier than previous methods. The company's WATS3D technology is included as an adjunct to routine biopsies for screening and surveillance of Barrett's esophagus in the guidelines of the American Society for Gastrointestinal Endoscopy (ASGE). CDx Diagnostics is expanding its platform to other areas like bile duct, stomach, and colon cancers.